Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/192615
Title: | Early biomarkers of Williams-Beuren syndrome: a preclinical study in the CD mouse model |
Author: | Giannoccaro, Silvia Ferraguto, Celeste Petroni, Valeria Marcelly, Coline Nogues, Xavier Campuzano Uceda, María Victoria Pietropaolo, Susanna |
Keywords: | Síndrome de Williams Malalties mentals Marcadors bioquímics Trastorns de la conducta Producció de sons pels animals Ratolins (Animals de laboratori) Adolescència Williams syndrome Mental illness Biochemical markers Behavior disorders Sound production by animals Mice (Laboratory animals) Adolescence |
Issue Date: | 21-Jan-2023 |
Publisher: | MDPI |
Abstract: | Williams-Beuren syndrome (WBS) is a neurodevelopmental disorder caused by a chromosomic microdeletion (7q11.23). WBS has been modeled by a mouse line having a complete deletion (CD) of the equivalent mouse locus. This model has been largely used to investigate the etiopathological mechanisms of WBS, although pharmacological therapies have not been identified yet. Surprisingly, CD mice were so far mainly tested in adulthood, despite the developmental nature of WBS and the critical relevance of early timing for potential treatments. Here we provide for the first time a phenotypic characterization of CD mice of both sexes during infancy and adolescence, i.e., between birth and 7 weeks of age. CD pups of both sexes showed reduced body growth, delayed sensory development, and altered patterns of ultrasonic vocalizations and exploratory behaviors. Adolescent CD mice showed reduced locomotion and acoustic startle response, and altered social interaction and communication, the latter being more pronounced in female mice. Juvenile CD mutants of both sexes also displayed reduced brain weight, cortical and hippocampal dendritic length, and spine density. Our findings highlight the critical relevance of early neurobehavioral alterations as biomarkers of WBS pathology, underlying the importance of adolescence for identifying novel therapeutic targets for this neurological disorder. |
Note: | Reproducció del document publicat a: https://doi.org/10.3390/cells12030391 |
It is part of: | Cells, 2023, vol. 12, p. 391 |
URI: | http://hdl.handle.net/2445/192615 |
Related resource: | https://doi.org/10.3390/cells12030391 |
ISSN: | 2073-4409 |
Appears in Collections: | Articles publicats en revistes (Biomedicina) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
728440.pdf | 10.56 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License